ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

Central Europe Faces Massive Public Education, Environmental Problems, Related To Cancer

August 23, 1991

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

November 24, 1978